Watkins, Catherine Louise, Sayers, Edward John  ORCID: https://orcid.org/0000-0002-2621-1119, Allender, Christopher John, Barrow, David Anthony  ORCID: https://orcid.org/0000-0003-2096-7262, Fegan, Christopher Daniel  ORCID: https://orcid.org/0000-0001-9685-0621, Brennan, Paul  ORCID: https://orcid.org/0000-0001-8792-0499 and Jones, Arwyn Tomos  ORCID: https://orcid.org/0000-0003-2781-8905
      2011.
      
      Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8.
      Molecular Therapy
      19
      
        (12)
      
      , pp. 2124-2132.
      
      10.1038/mt.2011.175
    
  
  
       
       
     
         | 
      
Abstract
Delivering apoptosis inducing peptides to cells is an emerging area in cancer and molecular therapeutics. Here, we have identified an alternative mechanism of action for the proapoptotic chimeric peptide D-NuBCP-9-r8. Integral to D-NuBCP-9-r8 is the Nur-77-derived D-isoform sequence fsrslhsll that targets Bcl-2, and the cell-penetrating peptide (CPP) octaarginine (r8) that is required for intracellular delivery. We find that the N-terminal phenylalanine of fsrslhsll acts in synergy with the cell-penetrating moiety to enhance peptide uptake at low nontoxic levels and cause rapid membrane blebbing and cell necrosis at higher (IC50) concentrations. These effects were not observed when a single phenylalanine–alanine mutation was introduced at the N-terminus of D-NuBCP-9-r8. Using primary samples from chronic lymphocytic leukemia (CLL) patients and cancer cell lines, we show that NuBCP-9-r8 induced toxicity, via membrane disruption, is independent of Bcl-2 expression. Overall, this study demonstrates a new mechanism of action for this peptide and cautions its use as a highly specific entity for targeting Bcl-2. For delivery of therapeutic peptides the work emphasizes that key amino acids in cargo, located several residues away from the cell-penetrating sequence, can significantly influence their cellular uptake and mode of action.
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Pharmacy Schools > Medicine Schools > Engineering  | 
      
| Subjects: | R Medicine > R Medicine (General) R Medicine > RM Therapeutics. Pharmacology  | 
      
| Publisher: | Nature Publishing Group: Open Access Hybrid Model Option B | 
| ISSN: | 1525-0016 | 
| Last Modified: | 06 Jan 2024 04:33 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/15593 | 
Citation Data
Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]()  | 
              Edit Item | 

							



 Altmetric
 Altmetric